Nanomaterials in Personalized Medicine Global Markets Report 2023-2028 with Profiles and Potential of Major Players - BMS, Camurus, Cytimmune Sciences, Eisai, Gilead Sciences, and Ipsen Pharma

News provided by

Nov 15, 2023, 19:00 ET

DUBLIN, Nov. 15, 2023 /PRNewswire/ -- The "Nanomaterials in Personalized Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for nanomaterials in personalized medicine was valued at $312.8 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to reach $592.0 billion in 2028.

The growth of the global market is attributed to factors such as the rising prevalence of chronic diseases globally, rising cancer cases globally, increasing number of diabetes cases worldwide, and rising worldwide cases of hypercholesterolemia

This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.

The field of personalized medicine has entered a new, revolutionary frontier with nanomaterials, which is transforming healthcare at the molecular level. These minute marvels, created with accuracy and cleverness, hold the key to a new era of personalized therapies and diagnostics, ushering in a day when medicine is as distinctive as the person it treats. Nanomaterials represent the pinnacle of innovation in the search for personalized healthcare solutions, opening up countless opportunities to improve patient care and transform the field of medicine.

The increasing prevalence of chronic diseases is boosting the already growing demand for global nanomaterials in the personalized medicine market. Chronic disease affects hundreds of million patients globally. Approximately 45% of Americans, or 133 million people, suffer from one or more chronic healthcare conditions. Similarly, in Europe, nearly 60 million people have more than one chronic disease. Chronic disease prevalence is expected to rise rapidly in the forecast period (2023-2028), and this is expected to create a significant burden on global healthcare.

Similarly, inorganic strategies amongst market players are also boosting the global market for nanomaterials in personalized medicine. For instance, in June 2023, Merck, often known as MSD outside of North America and Canada, acquired Prometheus Biosciences Inc., a biotechnology business in the clinical stages that is leading the way in precision medicine by finding, creating and commercializing innovative therapeutic and companion diagnostic solutions to treat immune-mediated disorders.

The Prometheus purchase strengthens Merck's pipeline; this will expand its immunology presence and enhance its capacity to provide patient value. This acquisition will support Merck to change how patients with immune-mediated disorders are treated thanks to the possible best-in-class candidate that Prometheus brings to the table.

The other vital driving factors are rising cancer cases globally, increasing number of diabetes cases worldwide, rising worldwide cases of hypercholesterolemia, and cross-industry collaborations and mergers; these are anticipated to increase the demand for nanomaterials in personalized medicine during the forecast period. However, challenges in nanomaterials in personalized medicine will likely impede market growth during the forecast period.

Major players in the nanomaterials in personalized medicine markets include Bristol-Myers Squibb Co., Eisai Co. Ltd., Gilead Sciences, Ipsen SA, and many others. All the major and emerging players are offering potential personalized nanomedicine for various therapeutic areas.

Company Profiles of Major Players

Bristol-Myers Squibb
Camurus Ab
Cytimmune Sciences
Eisai
Gilead Sciences Inc.
Ipsen Pharma

Key Topics Covered:

Chapter 1 Introduction

Overview of Nanotheranostics
Polymeric Nanomaterials
Magnetic Nanomaterials
Silica-Based Nanomaterials
Carbon Nanomaterials
Composite Nanomaterials
Biologic Nanomaterials: Antibody, Proteins and Dna
Carbon Nanotubes
Other Nanomaterials
Multifunctional Nanomaterials
Drug Delivery
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Market Insights

Chapter 3 Market Overview

Market Overview
Theranostics and Personalized Medicines Overview
Nanoparticles
Passive Targeting
Active Targeting
Nanotechnology Overview
Size Definition
Shape
Surface Area
Nanotheranostic Drug Delivery
In Vivo Drug-Release Studies
Drug Efficacy
Future Perspectives

Chapter 4 Nanodevices and Nanomaterials in Diagnostics

Overview
Molecular Recognition in Diagnosis
Nanopatterned Devices
Particles
Carbon Nanotubes
Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
Cancer Photothermal Therapy
Carbon Nanotubes for Other Therapeutic Applications
Fullerene C60
C60 Toxicity
Uptake and Biodistribution
Antioxidant Properties
Endohedrals
Magnetic Resonance Imaging
Radionuclides
Photodynamic Therapy
Dna Photocleavage
Cancer
Enzymes, Viruses, and Bacteria Inhibition
Drug and Gene Delivery
Magnetic Nanoparticles
Hyperthermia
Magnetic Separation
Imaging and Delivery
Brain Tumor Delivery
Prostate Cancer
Bladder Tumors
Quantum Dots
Aptamer-Conjugated Nanoparticles
Nanoparticle-Based Bio-Bar Codes
Multiplex Dendrimers
Surface Enhanced Raman Spectroscopy
Diagnostic and Medical Device Industry
Multifunctional Nanoparticles
Polymeric Nanoparticles in Cancer Therapy
Polymeric-Based Imaging Probes for Cancer Imaging
Quantum Dots in Cancer Imaging and Therapy
Quantum Dots in Photodynamic Therapy and Imaging
Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
Gold Nanoparticles for Photothermal Therapy
Gold Nanoshells
Gold Nanorods
Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
Conclusion and Future Trends

Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices

Infections Associated with Medical Devices and Their Treatments
Catheter-Associated Infections
Soft-Tissue-Implant-Associated Infections
Biofilm Formation
Common Methods for Preventing and Treating Medical Device-Associated Infections
Nanomaterials in Medical Applications
Nanomaterials in Personalized Medicine
Antimicrobial Nanomaterials
Silver Nanoparticles
Zinc Oxide
Iron and Iron-Oxide Nanoparticles
Titanium Oxide
Carbon Nanotubes and Fullerenes
Chitosan
Cytotoxicity Consideration

Chapter 6 Biomedical Nanoparticle Products

Introduction
Contract Manufacturing Organizations
Information Technology
Nanoparticle Drug Delivery Systems and Products
Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery

Chapter 7 Therapeutic and Diagnostic Companion Kits

Introduction

Chapter 8 Market Dynamics

Market Drivers
Rising Prevalence of Chronic Diseases Globally
Rising Cancer Cases Globally
Cancer Mortality
Increasing Number of Diabetes Cases Worldwide
Rising Worldwide Cases of Hypercholesterolemia
Other Major Drivers in the Personalized Medicine Market Are:
Market Restraints
Challenges with Personalized Medicine
Market Opportunities
Nanodrug Delivery for the Treatment of Neurological Disorders
Increasing Government Investment in Healthcare Sectors
Rising Healthcare Costs
Consumer Expectations

Chapter 9 Regulatory Landscape

Overview
Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
Regulatory Issues in Nanotechnology
Nanomedicines in the Pharmaceutical Market
Market Access and Pharmacoeconomics

Chapter 10 Impact of COVID-19 on the Market

Overview
Structure of COVID-19 and Penetration
COVID-19 Crisis
Impact of COVID-19 on Nanomaterials in Personalized Medicine
Novel Coronavirus Relying on Various Approaches
Challenges in Vaccine Disruptions
Components and Methods in the Design of a Vaccine
Antigens
Adjuvants
Nanoparticles/Nanocarriers
Devices
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusions Regarding Use of Nanotechnology to Combat COVID-19
COVID-19 Measures

Chapter 11 Market Breakdown by Product Type

Market Overview
Proteins
Monoclonal Antibodies (Mabs)
Monoclonal Antibody Therapy
Mechanism
Nanocrystals
Nanocrystals Fabrication
Liposomes
Liposome Classification and Preparation
Sonication
Extrusion
Freeze-Thawed Liposomes
Solvent Dispersion Method
Detergent-Removal Method
Stealth Liposome
Antibody-Liposome Conjugate
Liposome Application in Medicine and Pharmacology
Liposomes in Parasite Diseases and Infections
Liposomes in Anticancer Therapies
In Vitro Optical Imaging
Gold Nanocarrier
Hyperthermia
Contrast Enhancers
Radiotherapy
Quantum Dots as Nanocarriers
Photophysical Properties, Drug-Delivery and Drug-Release Sensing
Visualizing Intracellular Uptake in Vitro
Nanocarrier Biodistribution in Vivo
Short Interfering Rna and Dna Delivery

Chapter 12 Market Breakdown by Region

Overview
North America
U.S. Market Size and Forecast
Canada Market Size and Forecast
Europe
Germany Market Size and Forecast
U.K. Market Size and Forecast
France Market Size and Forecast
Italy Market Size and Forecast
Spain Market Size and Forecast
Rest of European Market Size and Forecast
Asia-Pacific
China Market Size and Forecast
Japan Market Size and Forecast
India Market Size and Forecast
South Korea Market Size and Forecast
Rest of Asia-Pacific Market Size and Forecast
Rest of the World
South America Market Size and Forecast
Middle East and Africa Market Size and Forecast

Chapter 13 Esg Development

Introduction to Esg
Environmental
Social
Government
The Sustainability of Major Companies in the Industry
Pharma End-user Sustainability in the Industry
Case Study
Concluding Remarks

Chapter 14 Emerging Technologies

Overview
Current Market Trends
Emerging Technologies
Biomarkers
Deep Phenotyping Technologies
Digital Precision Medicine
Genetics
Health Information Technology

Chapter 15 Patents and Pipeline Analysis

Overview
Patent Analysis
Pipeline Analysis

Chapter 16 M&A Outlook

M&A Analysis
Major Strategic Alliances

For more information about this report visit https://www.researchandmarkets.com/r/es9t3i

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets